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Abstract
BACKGROUND: Probiotics are living microorganisms that confer a health benefit when administered in adequate 
amounts. There is evidence in the current literature about the importance of probiotic use in pregnancy. The early 
supplementation of probiotics in the perinatal and postnatal periods seems to have a positive impact on the overall 
mother’s health and future health of infants.
AIM: Our pilot study aimed to test the ability of specific probiotics strains in combination with the kiwi-unique enzyme 
actinidin to improve the availability of folic acid in 20 pregnant women.
METHODS: We investigate 20 pregnant women in early (4–10 weeks) (6 patients), intermedium (11–20 weeks) (6 
patients), and late (21–30 weeks) (8 patients) pregnancy.
RESULTS: Our findings show that the tested formula promotes increased concentration of serum folate in women’s 
blood and contributes to the control of blood sugar and body weight, regardless of the gestational period (early, 
intermediate or late).
CONCLUSIONS: Our data support the main results reported in the scientific literature about the importance of 
probiotics intake in pregnancy.
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Introduction
Breast milk is known to be the best form 
of nutrition for newborns, especially for those born 
preterm. Variation in the composition of fatty acids in 
infant feeding can influence the microbial composition 
of the gut. The use of prebiotics and probiotics to 
stimulate gut microbial composition is increasingly 
compelling evidence [1].
The prevalence of allergies in newborns is 
about 10%, but it can reach 20–30% in those with a 
first-degree allergic relative [2], [3]. Prebiotics promote 
particular changes in the gastrointestinal microflora, 
regard composition and activity [4]. They influence 
immune response, and their supplementation has been 
proposed as a way to prevent allergic diseases but 
also of a different nature, as in the case of oncological 
diseases [2], [3], [4]. Preterm birth is the main cause of 
death in newborns; moreover, it represents a risk factor 
for adverse health outcomes: Nutritional approaches 
are a promising solution; among them, the use of zinc-
folic acid, combined iron-folate, and probiotics [5].
Numerous studies in the literature confirm 
that the nutrition of women in pregnancy and 
especially during breastfeeding influences the growth, 
development, and health of the baby in intrauterine and 
extrauterine life [6]. According to the latest data, poor 
nutrition during pregnancy can lead to spontaneous 
abortion or to a premature birth [7].
The first evidence of the importance of probiotic 
use in pregnancy was found on blood glucose values. 
Laitinen et al. [7] compared three intervention groups in a 
Finnish population of 256 pregnant women. The different 
groups followed three different models of nutrition: The 
first group followed a specific diet with probiotics, a 
second group a diet with a placebo effect, and a third and 
last control group followed a single and unique placebo 
diet. Women received the probiotic supplementation, 
containing Lactobacillus and Bifidobacterium, from the 
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early period to the postpartum period: In the test group, 
the normal diet supplemented with the use of probiotics 
had significantly reduced blood sugar values in the third 
trimester and consequently showed an improvement 
in insulin sensitivity [8]. Similarly, probiotics appear to 
show antioxidant properties as an iron-reducing activity 
in pregnant women [9].
The use of probiotics helps to maintain intestinal 
eubiosis and to control metabolic and immune changes, 
including the prevention of pathological situations both 
for the mother and the infant [10].
Our pilot study aimed to assess the benefits 
of the ability of specific probiotics strains in combined 
formula with the kiwi-unique enzyme actinidin to 
improve the availability of folic acid in pregnant women.
Materials and Methods
Participants
The Institutional Ethics Committee of the 
Faculty of Technical Medical Sciences of Elbasan 
“ALEKSANDËR XHUVANI” has approved the 
application to conduct the clinical trial in the Faculty. 
Title of the Protocol: Probiotics efficacy and safety in 
humans. Protocol identification: INTL_ALITCOOP/
Probiotics/INRES2019_w/a/c.
The study was carried out according to the 
Helsinki declaration and informed written consent was 
obtained from all the subjects.
Folate and folic acid intakes of 20 pregnant 
women were assessed in early (4–10 weeks) (6 patients), 
intermedium (11–20 weeks) (6 patients), and late (21–30 
weeks) (8 patients) pregnancy. Blood concentrations of 
folate and unmetabolized folic acid were measured with 
the use of immunoassays and liquid chromatography-
mass spectrometry, respectively, in maternal samples in 
early, intermedium, and late pregnancy. Participants did 
not take antibiotics for ≥3 months before participating 
in the study. Furthermore, participants did not take 
drugs or food supplements (e.g., folate-rich foods) 
that could influence the dependent variables; a health 
history questionnaire was provided from investigators. 
Prebiotic/probiotic foods (e.g., yogurt) have not been 
included in their diet. Participants were able to consume 
450 g/day (~16 fl. oz./day) of black coffee with caffeine 
or unsweetened black tea if used to consuming them 
regularly.
Targeted probiotic strains (TPS) specifically 
chosen for the support they can provide to pregnant 
and breastfeeding moms such as encouraging nutrient 
absorption, supporting the production of natural (non-
synthetic) folate, and breastfeeding and immune 
system support: Bifidobacterium infantis, Lactobacillus 
rhamnosus, Lactobacillus plantarum, Lactobacillus 
fermentum, Lactobacillus reuteri, and Lactobacillus 
acidophilus in combination with the kiwi-unique enzyme 
actinidin (Kiwifruit Powder). The formula containing 
5 Billion colony forming units† (CFUs) per BIO-tract® 
tablet, which is equivalent to 75 Billion CFU of probiotic 
veggie capsules. Moreover, the Kiwifruit Powder is a 
whole food that helps patients’ probiotics colonize and 
naturally supports regularity, a common concern during 
pregnancy.
Experimental design
The tested formula (PRO-MOM Hyperbiotics, 
USA) contains six TPS specifically chosen for the 
support they can provide to pregnant and breastfeeding 
moms such as encouraging nutrient absorption, 
supporting the production of natural (non-synthetic) 
folate, and breastfeeding and immune system support: 
B. infantis, L. rhamnosus, L. plantarum, L. fermentum, 
L. reuteri, and L. acidophilus in combination with the 
kiwi-unique enzyme actinidin (Kiwifruit Powder). The 
formula containing 5 Billion CFUs† per BIO-tract® 
tablet, which is equivalent to 75 Billion CFU of probiotic 
veggie capsules. Moreover, the Kiwifruit Powder is a 
whole food that helps patients’ probiotics colonize and 
naturally supports regularity, a common concern during 
pregnancy.
A randomized, double-blind, and placebo-
controlled parallel-group investigation was applied for 
this study. After completing baseline measures, the 
participants were divided by age and month of pregnancy 
and randomized into one of two groups: integration with 
PRO-MOM Hyperbiotics, USA (1 tablet per day) (test 
group) or without probiotic administration (placebo group). 
Measurements of key outcome variables (body weight) 
were performed at baseline (T0) and after the 8-week 
treatment period (T1) within each of the three groups (early, 
intermediate, and late – pregnancy). All measurements 
were taken between 7:00 am and 11:00 am. Blood was 
collected at baseline and after 8 weeks of treatment for 
glycemic control and serum folate status.
Statistical analysis
Outcome measures were analyzed with a 
t-test for paired samples for pre-post differences with 
time as the factor using (Statistical Package for the 
Social Sciences for Windows, Version 11.5, Chicago, 
Ill) software to detect significant differences between 
pre-test and post-test scores.
Results
Furthermore, on the first visit, the participants 
were instructed on the objectives and methods of 
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clinical trials. Subjects who agreed to participate in the 
study, after having signed the informed consent, were 
randomly included and divided into two groups: A test 
group using probiotics, instead, the other group of a 
placebo, without probiotics.
Twenty people were enrolled as follows:
a. Placebo group: 3 early, 3 intermedium, and 4 late
b. Test group: 3 early, 3 intermedium, and 4 late.
Folate values
Serum folate concentration was measured 
in the placebo group and test group at T0 and T1. 
Laboratory values were carefully analyzed and reported 
in Table 1.
Table 1: Blood concentration of folate in the placebo group 
and test group at T0 and T1.
Blood concentration of folate: Placebo group Blood concentration of folate: Test group
ID Pregnancy 
period
T0  
(ng/ml)
T1  
(ng/ml)
ID Pregnancy 
period
T0  
(ng/ml)
T1  
(ng/ml)
EA Early 5.5 7.3 MM Early 7 10
CB Early 6 8.8 AC Early 7.8 10.1
FG Early 7.3 9 PA Early 6.2 9.1
IM Intermedium 9.9 11.5 FV Intermedium 11.9 13.9
MT Intermedium 11 12.9 ACC Intermedium 10 12.7
RR Intermedium 12.7 13.9 BG Intermedium 11 14
SA Late 16 18.1 KL Late 17 19.8
FT Late 15.3 16.8 VF Late 18 21
MTO Late 18 20 DC Late 16.5 19.7
FP Late 16.9 19.2 ST Late 19 21.8
Moreover, serum folate values were evaluated 
at time T0 and T1 in placebo group and test group.
As shown in Figure 1a, the trend of serum 
folate values was evaluated at time T0 and T1 in the 
placebo group. The results showed an increasing trend 
of around 16% from baseline to T1, since during the 
gestation period, folate levels increase, linked to the 
supplements that pregnant women usually implement 
in their diet.
In Figure 1b, the trend of serum folate values 
was evaluated at time T0 and T1 in the test group. The 
results showed a variation of blood folate levels from 
T0 to T1 in the test group. It should be noted that the 
data present at time 0 increased by about 22% at T1, a 
substantial increase compared to the conditions of the 
placebo.
In both groups, the T0 values are included 
in the standard ranges, which vary according to the 
gestation period: In the early period, folate values are 
slightly lower than in the intermediate and late one. 
Therefore, the resulting data show how prebiotic intake 
has been able to favor a greater increase in blood folate 
values.
Glycemia values
Blood glucose concentration was measured 
in the placebo group and test group at T0 and T1 and 
reported in Table 2.
Table 2: Glycemia in the placebo group and test group at T0 
and T1
Glycemia: Placebo group Glycemia: Test group
ID Pregnancy 
period
T0 
(mg/d)
T1  
(mg/dL)
ID Pregnancy 
period
T0  
(mg/dL)
T1  
(mg/dL)
EA Early 69 68.9 MM Early 67 65.3
CB Early 70 71 AC Early 78 76
FG Early 71 70 PA Early 77.9 76
IM Intermedium 67 66.8 FV Intermedium 67.9 65.5
MT Intermedium 65 66 ACC Intermedium 81 79.1
RR Intermedium 80 78.8 BG Intermedium 79.9 77
SA Late 79 78.5 KL Late 83.4 82
FT Late 76.4 77.7 VF Late 73 72
MTO Late 78 78 DC Late 75.7 73
FP Late 87.1 86.7 ST Late 82.3 80.4
Glycemia values were also evaluated at time 
T0 and T1 in placebo group and test group.
As shown in Figure 2a, the glucose 
concentration (mg/dL) does not vary substantially 
from T0 to T1 in the placebo group: The two lines 
overlap in the graph. Moreover, the obtained values 
are all lower than 92 mg/dL, which underlines the good 
health condition of women enrolled in T0 that is also 
maintained at T1.
As shown in Figure 2b, the glucose 
concentration (mg/dL) slightly varies from baseline 
to T1 in the test group after taking the probiotics: T1 
values are 2.5% lower than T0, which allows us to 
say that taking probiotics could help to control blood 
Figure 1: Serum folate concentration (ng/ml) at time T0 and T1 in placebo group and test group: (a) This graph shows the trend of serum folate 
values at time T0 and T1 in the placebo group. There is an increasing trend from baseline T0 to T1 of around 16%; (b) the graph shows how 
blood folate levels vary from T0 to T1 in the test group. It should be noted that T0 values increase by about 22% at T1 that is a substantial 
increase if compared to the placebo one. The results show that the probiotic intake promotes the increase of folate values in the blood
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glucose concentration; moreover, it could be a way to 
prevent gestational diabetes.
Weight values
Weight values were measured in the placebo 
group and test group at T0 and T1. Data were carefully 
analyzed and reported in Table 3.
Table 3: Weight in the placebo group at T0 and T1
Weight: Placebo group Weight: Test group
ID Pregnancy 
period
T0 (kg) T1 (kg) ID Pregnancy 
period
T0 (kg) T1 (kg)
EA Early 65 67 MM Early 54 55.1
CB Early 52 54.6 AC Early 59 60.1
FG Early 59.4 61.9 PA Early 70 72
IM Intermedium 51.5 53.7 FV Intermedium 56 57.3
MT Intermedium 56 59 ACC Intermedium 67 68.4
RR Intermedium 63.6 67 BG Intermedium 65 66.9
SA Late 53.9 55.8 KL Late 53 55
FT Late 61.6 64.2 VF Late 56.8 58
MTO Late 59 61.9 DC Late 64.1 65.8
FP Late 70 71.8 ST Late 54.9 56
Weight values were evaluated at time T0 and 
T1 in placebo group and test group.
As shown in Figure 3a, weight values slightly 
vary from baseline to T1 in the placebo group: There 
is a normal weight gain of 4% from T0 to T1 due to the 
physiological increase during pregnancy.
As shown in Figure 3b, weight values slightly 
vary from baseline to T1 in the test group: There is an 
increase of 2.5% from T0 to T1, which is a minimum 
increase if compared to the placebo group. This result 
allows us to underline that the use of probiotics is also 
useful for weight monitoring, an important factor to 
safeguard fetus health.
Discussion
It is well known that imbalances in the intake 
of macronutrients and micronutrients during pregnancy 
can alter the growth and development of the fetus, 
predisposing it to the risk of pathologies in recent and 
future times [10], [11]. According to a review conducted 
on Cochrane, from Haider and Bhutta, a diet, in pregnant 
women, enriched with micronutrients with iron and folic 
acid and with the external integration of prebiotics 
has resulted in a significant reduction of infants born 
with low weight but also a reduction equally significant 
number of infants born premature and/or dead [12]. This 
is about a 20% lower probability of women giving birth 
to children who will develop inflammations, atypical 
diseases compared to those women who do not include 
the use of probiotics in their diet [13]. On a practical 
plan, this corresponds to 44 cases of eczema per 
thousand children. To suggest, it is a study published 
by Kalliomäki et al. in 2007 [14].
A diet during the gestational period and in the 
2 months following birth, therefore, during lactation, 
rich in L. rhamnosus and Bifidobacterium lactis brings 
beneficial effects on maternal health, fetal growth, and 
morbidity of the baby [15]. The same use of probiotics 
can guarantee, even in part, good bone regeneration 
and prevent mothers from any pathologies related to 
bone and dental loss [16], [17], [18]. In fact, in a clinical 
study involving 208 mother/child couples, particular 
benefits were found after probiotics intake: There was 
constant maintenance of body weight in pregnant 
women, and an increase in length and a reduction in 
the incidence of diarrhea in the newborn [17].
In a recent study, L. plantarum A41 and 
L. fermentum SRK414 showed high probiotic potential 
and a strong impact on the bone health of pregnant 
women by modulating the production of pro-inflammatory 
cytokines and markers related to bone metabolism [18]. 
In line with even more recent studies, the use of 
translational researches in regenerative medicine, as 
well as the use of pharmacological nanotechnologies 
alongside the consumption of probiotics, can improve 
bone health in pregnancy by guaranteeing the right 
supply of calcium and micronutrients [19], [20].
According to a study conducted in 2018 and 
published by the World Nutritional Journal, Vitamin B12 
Figure 2: Blood glucose concentration (mg/dL) at time T0 and T1 in placebo group and test group: (a) The graph shows the glucose values 
in T0 and T1 in the placebo group: The two lines overlap and the trend of the graph is linear as there are no differences in the values; (b) the 
graph shows the glucose values in T0 and T1 in the test group: Glycemia varies from baseline to T1, reducing of 2.5% that is a great result to 
say that taking probiotics could help to control glycemia
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plays an important role in preventing congenital birth 
defects such as malformations to hydrocephalus and 
spina bifida [21].
In this randomized clinical study conducted 
on pregnant women, it has been shown how the 
intake, in the three gestational quarters, of probiotics 
increases the serum concentration of Vitamin B12. In 
particular, by integrating a normal probiotic containing 
Bifidobacterium animalis subsp. lactis (HNO19), blood 
levels of Vitamins B9 and B12 appear to increase in 
the 2nd and 3rd trimester. The consumption of pre and 
probiotics during the periconceptional period can be 
a useful strategy for improving maternal Vitamin B 
concentrations [22]. The British Journal of Nutrition 
has published the results of a randomized clinical trial 
according to which the problem of many pregnant 
women to develop gestational diabetes could be solved 
by the use of probiotics. The study was conducted 
on over 250 pregnant women and the results show 
a reduction in glucose concentration in women who 
have followed the diet supplemented with probiotics of 
approximately 20%. Glucose homeostasis guarantees 
optimal fetal growth with health implications before and 
after childbirth, both for mothers and newborns [7].
According to the results of a further study 
published in the Journal of Diabetes Investigation, 
in women with gestational diabetes, following a diet 
supplemented with probiotics for 4 weeks resulted in a 
reduction in fasting blood sugar and increased sensitivity 
to insulin. The study was conducted double-blind on 
57 women between 24 and 28 weeks of gestation. 
The participants were divided into two groups; the first 
group was assigned a diet with probiotics containing 
bifidobacteria and lactobacilli, while the second group 
took placebo. Feeding with probiotics for 4 weeks, 
between the end of the second and the beginning of 
the third trimester of pregnancy, resulted in positive 
metabolic changes in favor of fasting blood sugar. In 
fact, there has been a drop in blood glucose value. 
Furthermore, these effects were not accompanied by 
significant differences in weight gain between the two 
treatment groups. The authors have consequently 
shown how integration with probiotics has proven safe 
and well-tolerated by pregnant women. Kijmanawat 
et al., therefore, deduced that for women with 
gestational diabetes, supplementation with probiotics 
at 24–28 weeks of pregnancy can be considered an 
additional treatment for glycemic control [23]. In more 
recent times, the use of pharmacological therapy with 
the advent of nanotechnologies can also further improve 
the health of women with gestational diabetes [24]. In 
recent years, there have been several studies that have 
focused on the beneficial effects of probiotics in different 
fields [25], [26], [27], [28], [29], [30], [31], [32], [33], [34].
Conclusions
Based on the resulting data, our clinical study 
indicates that the supplementing probiotics of PRO-
MOM Hyperbiotics USA in the diet of pregnant women 
would bring numerous benefits to them, regardless of 
the gestational period (early, intermediate or late). In 
pregnant women enrolled in our study, taking probiotics 
favored the increased concentration of folate in the 
blood and contributed to the control of blood sugar and 
body weight. Our data confirmed and improved the 
main results reported in the scientific literature about 
the importance of probiotics intake in pregnancy.
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